Effect of renal impairment on the pharmacokinetics and tolerability of capecitabine (Xeloda) in cancer patients
- 1 March 2002
- journal article
- clinical trial
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 49 (3) , 225-234
- https://doi.org/10.1007/s00280-001-0408-0
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: